Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease (NCT06071429)
🩺 Plain-English Summary (8th-Grade Level)
The objective of this prospective, single-blinded, randomized controlled trial is to evaluate the safety and efficacy of the MAGNITUDE BRS System for the planned treatment of narrowed infrapopliteal lesions. Approximately 276 subjects will be randomized in a 1:1 ratio. The clinical investigation will be conducted at up to 60 clinical sites globally.
Who can join: Review the eligibility criteria below.
Location: NYU Langone Health — New York, New York
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- NYU Langone Health — New York, New York
- CUMC/NYP — New York, New York
- Staten Island University Hospital - Northwell Health — Staten Island, New York
📞 Contact the Study Coordinator
Phone: (904) 540-3844
Email: mhill@r3vascular.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Limb-Threatening Ischemia
- Esprit BTK Post-Approval Study — Scottsdale, Arizona
- Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study — Eisenstadt,
- BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI) — San Francisco, California
- Peripheral Bypass Trial for Completion Control — San Francisco, California
Explore by condition: All Chronic Limb-Threatening Ischemia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.